Wed, Oct 1, 2014, 1:11 AM EDT - U.S. Markets open in 8 hrs 19 mins


% | $
Quotes you view appear here for quick access.

DUSA Pharmaceuticals Inc. Message Board

  • janerockets janerockets Nov 8, 2012 8:09 AM Flag



    November 8, 2012

    New York, New York -- Tripp Levy PLLC, a leading national securities law firm, has commenced an investigation on behalf of shareholders of Dusa Pharmaceuticals. It was announced that Sun Pharmaceutical Industries will acquire Dusa. Under the terms of the agreement, Sun Pharmaceutical Industries will commence a tender offer for all of the outstanding common stock of DUSA at a price of $8.00 per share in cash.

    The investigation concerns whether the board of directors of Dusa breached their fiduciary duties to shareholders by not obtaining a higher price through a full and fair auction process while not obtaining personal benefits for themselves to sell the company at this price. Indeed, analysts have projected that the true take out value of the company is worth at least $9.50 per share.

    If you are a shareholder of Dusa and would like additional information, please contact us toll free at 877-772-3975 or email at contact @ tripplevy

    Tripp Levy PLLC is a leading national law firm that has recovered millions for shareholders around the globe.

    This topic is deleted.

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Cyber-Ark Software Ltd.
NasdaqGSTue, Sep 30, 2014 4:00 PM EDT
eBay Inc.
NasdaqGSTue, Sep 30, 2014 4:15 PM EDT
Move, Inc.
NasdaqGSTue, Sep 30, 2014 4:00 PM EDT